+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Prescription Drugs Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type, Drug Type, Therapeutic Area, Route Of Administration, Distribution Channel, and Geography- Product Image
Prescription Drugs Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type, Drug Type, Therapeutic Area, Route Of Administration, Distribution Channel, and Geography- Product Image
New

Prescription Drugs Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type, Drug Type, Therapeutic Area, Route Of Administration, Distribution Channel, and Geography

  • PDF Icon

    Report

  • 329 Pages
  • July 2025
  • Region: Global
  • The Insight Partners
  • ID: 6114279
Description Jump to:
According to our new research study on “Prescription Drugs Market Forecast to 2031 -Global Analysis - by Product Type, Drug Type, Route Of Administration, Therapeutic Area, And Distribution Channel,” the market is anticipated to grow from US$ 1.44 trillion in 2024 and is projected to reach US$ 2.35 trillion by 2031; it is expected to register a CAGR of 7.3% from 2025 to 2031. The prescription drugs market growth is attributed to the increasing prevalence of chronic disorders and development and adoption of innovative and specialty drugs.

Prescription drugs are medications that legally require a medical prescription from a licensed healthcare professional. They are regulated because they can have significant effects on the body, require monitoring for safety, or have potential for misuse.

The prescription drugs market in North America is segmented into the US, Canada, and Mexico. North America is likely to capture a significant share of the global market. One of the primary drivers is the region’s aging population. As the baby boomer generation grows older, the prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer has increased, thereby boosting the demand for prescription medications.

Advancements in pharmaceutical research and biotechnology have also played a critical role. Innovations in drug development, including biologics and personalized medicine, have expanded treatment options, enhancing efficacy and safety. The introduction of novel therapies for previously untreatable conditions has further propelled market growth.

Another major contributor is the strong healthcare infrastructure in North America, supported by substantial investments in healthcare facilities, insurance coverage, and pharmaceutical distribution networks. The widespread availability of healthcare services and better patient awareness about disease management have increased prescription drug consumption.

Additionally, regulatory support from agencies such as the US Food and Drug Administration (FDA) facilitates quicker approval processes for innovative drugs, enabling faster market entry. Furthermore, government initiatives aimed at expanding healthcare coverage, such as the Affordable Care Act in the US, have increased access to prescription drugs for a broader population.

Also, the rise in lifestyle-related diseases and increased prevalence of mental health disorders have created a sustained demand for therapeutic drugs. The COVID-19 pandemic also emphasized the importance of pharmaceutical interventions, accelerating investments in drug development and distribution.

In North America, the US holds a significant share of the prescription drugs market. Chronic conditions such as cancer, heart disease, and diabetes are contributing to the rising demand for prescription medications. Heart disease remains the leading cause of death in the US, with nearly one million Americans annually succumbing to cardiovascular disease (CVD).

According to the American Heart Association, nearly half of all adults in the US have some type of CVD, and it is estimated that the number of adults suffering from heart failure is projected to increase by 2035. Over 130 million adults, i.e., 45.1% of the US population, are expected to report some form of CVD by 2035. This surge in CVD cases leads to a higher number of patients requiring long-term medication management, including statins, beta-blockers, anticoagulants, and antihypertensive drugs.

According to the American Cancer Society, in 2022, ~1.9 million new cases of cancer were diagnosed in the country, and it caused ~0.61 million deaths. With the increasing cases of cancer, the demand for innovative treatment options is rising. Therapeutic vaccines offer promising alternatives to traditional therapies. Provenge (sipuleucel-T), approved by the FDA in 2010, is the first therapeutic cancer vaccine to receive approval and prescribed medication for cancer treatment. Additionally, advancements in oncology, immunology, and gene therapies are expanding treatment options for various cancers and autoimmune diseases. Despite these advancements, prescription drug spending continues to rise.

According to the American Society of Health-System Pharmacists, in 2024, Americans spent US$ 805.9 billion on prescription drugs, a 10.2% increase from the previous year. This increase is attributed to higher demand for these medications and the introduction of new, expensive treatments. Additionally, 79% of Americans believe that prescription drug prices are "unreasonable," while 70% consider reducing these costs to be their top healthcare priority. According to the Rand Corporation, on average, prescription drug prices in the US are 2.56 times higher than those in 32 other Organization for Economic Co-operation and Development (OECD) countries, with brand-name medications costing 3.44 times more.

To address these costs, the Inflation Reduction Act (IRA), which aims to negotiate drug prices for Medicare, was introduced. In 2024, the US government finalized prices for the first ten drugs under the IRA 2022, marking a significant milestone. After months of negotiations with drug manufacturers, prices for medications such as Stelara and Jardiance have reduced by 38% to 79%. These changes are anticipated to save taxpayers US$6 billion by 2026 and provide US$1.5 billion in savings for patients.

While spending continues to rise, legislative efforts are underway to make medications more affordable for Americans. In May 2025, President Donald Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” Trump stated that the order aims to align the prices Americans and taxpayers pay for prescription drugs with those paid in comparable countries. The measure is expected to cut drug prices by at least 50% and is characterized as a more aggressive version of Trump’s 2020 Most Favored Nation model.

Growth of Personalized and Precision Medicine to Provide Market Opportunities in Future
Personalized and precision medicine is experiencing growing technological advancements, increasing understanding of genomics, and rising adoption of personalized therapeutic approaches. Personalized medicine involves customizing healthcare based on individual genetic, environmental, and lifestyle factors, allowing for more effective and targeted treatments.

The development of targeted cancer therapies such as trastuzumab (Herceptin) for HER2-positive breast cancer exemplifies how genetic profiling can identify patients who will benefit most from specific treatments, improving efficacy and reducing adverse effects. The increasing adoption of companion diagnostics is expected to integrate genetic testing into routine clinical practice, enhancing drug efficacy and safety.

Technological advancements such as artificial intelligence (AI) and big data analytics are accelerating discoveries in personalized medicine. AI-driven algorithms analyze vast datasets to predict individual responses to drugs, identify new therapeutic targets, and streamline drug development processes. For instance, companies such as Tempus are harnessing AI to tailor cancer treatments based on patients' genetic profiles, offering more precise and effective interventions. Therefore, technological innovations and increasing clinical adoption of more effective, safer, and patient-centric therapies, transforming healthcare delivery and outcomes globally, are expected to contribute to the market growth in coming years.

The US Food and Drug Administration, National Cancer Institute, European Medicines Agency, Central Drugs Standard Control Organization, and Our World in data are among the primary and secondary sources referred to while preparing the prescription drugs market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the prescription drugs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the prescription drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the prescription drugs market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Prescription Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Prescription Drugs Market - Key Market Dynamics
5.1 Prescription Drugs Market - Key Market Dynamics
5.2 Market Drivers:
5.2.1 Increasing Prevalence of Chronic Disorders
5.2.2 Development and Adoption of Innovative and Specialty Drugs
5.3 Market Restraints
5.3.1 High Drug Prices and Affordability Issues
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Growth of Personalized and Precision Medicine
5.6 Impact of Drivers and Restraints:
6. Prescription Drugs Market - Global Market Analysis
6.1 Prescription Drugs Market Revenue (US$ Billion), 2021-2031
6.2 Prescription Drugs Market Forecast Analysis
7. Prescription Drugs Market Analysis - by Product Type
7.1 Branded
7.1.1 Overview
7.1.2 Branded: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
7.2 Generics
7.2.1 Overview
7.2.2 Generics: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8. Prescription Drugs Market Analysis - by Drug Type
8.1 Small Molecule
8.1.1 Overview
8.1.2 Small Molecule: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8.2 Biologics and Biosimilar
8.2.1 Overview
8.2.2 Biologics and Biosimilar: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
9. Prescription Drugs Market Analysis - by Therapeutic Area
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
9.2 Cardiovascular Diseases
9.2.1 Overview
9.2.2 Cardiovascular Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Neurological Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
9.4 Metabolic Diseases
9.4.1 Overview
9.4.2 Metabolic Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
9.5 Respiratory Diseases
9.5.1 Overview
9.5.2 Respiratory Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
9.7 Others
9.7.1 Overview
9.7.2 Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
10. Prescription Drugs Market Analysis - by Route Of Administration
10.1 Oral
10.1.1 Overview
10.1.2 Oral: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
10.2 Injectable
10.2.1 Overview
10.2.2 Injectable: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
10.3 Topical
10.3.1 Overview
10.3.2 Topical: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
10.4 Others
10.4.1 Overview
10.4.2 Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
11. Prescription Drugs Market Analysis - by Distribution Channel
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
12. Prescription Drugs Market - Geographical Analysis
12.1 North America
12.1.1 North America Prescription Drugs Market Overview
12.1.2 North America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
12.1.2.1 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
12.1.2.2 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
12.1.2.3 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
12.1.2.4 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.1.2.5 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.1.3 North America: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
12.1.3.1 United States: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.1.3.1.1 United States: Prescription Drugs Market Breakdown, by Product Type
12.1.3.1.2 United States: Prescription Drugs Market Breakdown, by Drug Type
12.1.3.1.3 United States: Prescription Drugs Market Breakdown, by Therapeutic Area
12.1.3.1.4 United States: Prescription Drugs Market Breakdown, by Route Of Administration
12.1.3.1.5 United States: Prescription Drugs Market Breakdown, by Distribution Channel
12.1.3.2 Canada: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.1.3.2.1 Canada: Prescription Drugs Market Breakdown, by Product Type
12.1.3.2.2 Canada: Prescription Drugs Market Breakdown, by Drug Type
12.1.3.2.3 Canada: Prescription Drugs Market Breakdown, by Therapeutic Area
12.1.3.2.4 Canada: Prescription Drugs Market Breakdown, by Route Of Administration
12.1.3.2.5 Canada: Prescription Drugs Market Breakdown, by Distribution Channel
12.1.3.3 Mexico: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.1.3.3.1 Mexico: Prescription Drugs Market Breakdown, by Product Type
12.1.3.3.2 Mexico: Prescription Drugs Market Breakdown, by Drug Type
12.1.3.3.3 Mexico: Prescription Drugs Market Breakdown, by Therapeutic Area
12.1.3.3.4 Mexico: Prescription Drugs Market Breakdown, by Route Of Administration
12.1.3.3.5 Mexico: Prescription Drugs Market Breakdown, by Distribution Channel
12.2 Europe
12.2.1 Europe Prescription Drugs Market Overview
12.2.2 Europe: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
12.2.2.1 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
12.2.2.2 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
12.2.2.3 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
12.2.2.4 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.2.2.5 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.2.3 Europe: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
12.2.3.1 Germany: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.2.3.1.1 Germany: Prescription Drugs Market Breakdown, by Product Type
12.2.3.1.2 Germany: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.1.3 Germany: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.1.4 Germany: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.1.5 Germany: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.2 United Kingdom: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.2.3.2.1 United Kingdom: Prescription Drugs Market Breakdown, by Product Type
12.2.3.2.2 United Kingdom: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.2.3 United Kingdom: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.2.4 United Kingdom: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.2.5 United Kingdom: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.3 France: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.2.3.3.1 France: Prescription Drugs Market Breakdown, by Product Type
12.2.3.3.2 France: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.3.3 France: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.3.4 France: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.3.5 France: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.4 Italy: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.2.3.4.1 Italy: Prescription Drugs Market Breakdown, by Product Type
12.2.3.4.2 Italy: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.4.3 Italy: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.4.4 Italy: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.4.5 Italy: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.5 Spain: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.2.3.5.1 Spain: Prescription Drugs Market Breakdown, by Product Type
12.2.3.5.2 Spain: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.5.3 Spain: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.5.4 Spain: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.5.5 Spain: Prescription Drugs Market Breakdown, by Distribution Channel
12.2.3.6 Rest of Europe: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.2.3.6.1 Rest of Europe: Prescription Drugs Market Breakdown, by Product Type
12.2.3.6.2 Rest of Europe: Prescription Drugs Market Breakdown, by Drug Type
12.2.3.6.3 Rest of Europe: Prescription Drugs Market Breakdown, by Therapeutic Area
12.2.3.6.4 Rest of Europe: Prescription Drugs Market Breakdown, by Route Of Administration
12.2.3.6.5 Rest of Europe: Prescription Drugs Market Breakdown, by Distribution Channel
12.3 Asia Pacific
12.3.1 Asia Pacific Prescription Drugs Market Overview
12.3.2 Asia Pacific: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
12.3.2.1 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
12.3.2.2 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
12.3.2.3 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
12.3.2.4 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.3.2.5 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.3.3 Asia Pacific: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
12.3.3.1 China: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.3.3.1.1 China: Prescription Drugs Market Breakdown, by Product Type
12.3.3.1.2 China: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.1.3 China: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.1.4 China: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.1.5 China: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.2 Japan: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.3.3.2.1 Japan: Prescription Drugs Market Breakdown, by Product Type
12.3.3.2.2 Japan: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.2.3 Japan: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.2.4 Japan: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.2.5 Japan: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.3 India: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.3.3.3.1 India: Prescription Drugs Market Breakdown, by Product Type
12.3.3.3.2 India: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.3.3 India: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.3.4 India: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.3.5 India: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.4 Australia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.3.3.4.1 Australia: Prescription Drugs Market Breakdown, by Product Type
12.3.3.4.2 Australia: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.4.3 Australia: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.4.4 Australia: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.4.5 Australia: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.5 South Korea: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.3.3.5.1 South Korea: Prescription Drugs Market Breakdown, by Product Type
12.3.3.5.2 South Korea: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.5.3 South Korea: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.5.4 South Korea: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.5.5 South Korea: Prescription Drugs Market Breakdown, by Distribution Channel
12.3.3.6 Rest of APAC: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.3.3.6.1 Rest of APAC: Prescription Drugs Market Breakdown, by Product Type
12.3.3.6.2 Rest of APAC: Prescription Drugs Market Breakdown, by Drug Type
12.3.3.6.3 Rest of APAC: Prescription Drugs Market Breakdown, by Therapeutic Area
12.3.3.6.4 Rest of APAC: Prescription Drugs Market Breakdown, by Route Of Administration
12.3.3.6.5 Rest of APAC: Prescription Drugs Market Breakdown, by Distribution Channel
12.4 Middle East and Africa
12.4.1 Middle East and Africa Prescription Drugs Market Overview
12.4.2 Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
12.4.2.1 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
12.4.2.2 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
12.4.2.3 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
12.4.2.4 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.4.2.5 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.4.3 Middle East and Africa: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
12.4.3.1 Saudi Arabia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.4.3.1.1 Saudi Arabia: Prescription Drugs Market Breakdown, by Product Type
12.4.3.1.2 Saudi Arabia: Prescription Drugs Market Breakdown, by Drug Type
12.4.3.1.3 Saudi Arabia: Prescription Drugs Market Breakdown, by Therapeutic Area
12.4.3.1.4 Saudi Arabia: Prescription Drugs Market Breakdown, by Route Of Administration
12.4.3.1.5 Saudi Arabia: Prescription Drugs Market Breakdown, by Distribution Channel
12.4.3.2 South Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.4.3.2.1 South Africa: Prescription Drugs Market Breakdown, by Product Type
12.4.3.2.2 South Africa: Prescription Drugs Market Breakdown, by Drug Type
12.4.3.2.3 South Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
12.4.3.2.4 South Africa: Prescription Drugs Market Breakdown, by Route Of Administration
12.4.3.2.5 South Africa: Prescription Drugs Market Breakdown, by Distribution Channel
12.4.3.3 United Arab Emirates: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.4.3.3.1 United Arab Emirates: Prescription Drugs Market Breakdown, by Product Type
12.4.3.3.2 United Arab Emirates: Prescription Drugs Market Breakdown, by Drug Type
12.4.3.3.3 United Arab Emirates: Prescription Drugs Market Breakdown, by Therapeutic Area
12.4.3.3.4 United Arab Emirates: Prescription Drugs Market Breakdown, by Route Of Administration
12.4.3.3.5 United Arab Emirates: Prescription Drugs Market Breakdown, by Distribution Channel
12.4.3.4 Rest of Middle East and Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.4.3.4.1 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Product Type
12.4.3.4.2 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Drug Type
12.4.3.4.3 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Therapeutic Area
12.4.3.4.4 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Route Of Administration
12.4.3.4.5 Rest of Middle East and Africa: Prescription Drugs Market Breakdown, by Distribution Channel
12.5 South and Central America
12.5.1 South and Central America Prescription Drugs Market Overview
12.5.2 South and Central America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
12.5.2.1 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Product Type
12.5.2.2 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Drug Type
12.5.2.3 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Therapeutic Area
12.5.2.4 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.5.2.5 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.5.3 South and Central America: Prescription Drugs Market - Revenue and Forecast Analysis - by Country
12.5.3.1 Brazil: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.5.3.1.1 Brazil: Prescription Drugs Market Breakdown, by Product Type
12.5.3.1.2 Brazil: Prescription Drugs Market Breakdown, by Drug Type
12.5.3.1.3 Brazil: Prescription Drugs Market Breakdown, by Therapeutic Area
12.5.3.1.4 Brazil: Prescription Drugs Market Breakdown, by Route Of Administration
12.5.3.1.5 Brazil: Prescription Drugs Market Breakdown, by Distribution Channel
12.5.3.2 Argentina: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.5.3.2.1 Argentina: Prescription Drugs Market Breakdown, by Product Type
12.5.3.2.2 Argentina: Prescription Drugs Market Breakdown, by Drug Type
12.5.3.2.3 Argentina: Prescription Drugs Market Breakdown, by Therapeutic Area
12.5.3.2.4 Argentina: Prescription Drugs Market Breakdown, by Route Of Administration
12.5.3.2.5 Argentina: Prescription Drugs Market Breakdown, by Distribution Channel
12.5.3.3 Rest of South and Central America: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
12.5.3.3.1 Rest of South and Central America: Prescription Drugs Market Breakdown, by Product Type
12.5.3.3.2 Rest of South and Central America: Prescription Drugs Market Breakdown, by Drug Type
12.5.3.3.3 Rest of South and Central America: Prescription Drugs Market Breakdown, by Therapeutic Area
12.5.3.3.4 Rest of South and Central America: Prescription Drugs Market Breakdown, by Route Of Administration
12.5.3.3.5 Rest of South and Central America: Prescription Drugs Market Breakdown, by Distribution Channel
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14. Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Prescription Drugs Market
14.3 Organic Growth Strategies
14.3.1 Overview
14.4 Inorganic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 Johnson & Johnson
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Pfizer Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Merck & Co Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Eli Lilly and Co
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 ESTEVE
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 AstraZeneca Plc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Sanofi SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 GSK Plc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 F. Hoffmann-La Roche Ltd
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Novartis AG
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 AbbVie Inc
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Teva Pharmaceutical Industries Ltd
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. Appendix
16.1 About the Publisher
16.2 Glossary of Terms
LIST OF TABLES
Table 1. Prescription Drugs Market Segmentation
Table 2. Key Brands Facing Patent Expirations
Table 3. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 4. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 5. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 6. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 7. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 8. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 9. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 10. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 11. North America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 12. North America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 13. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 14. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 15. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 16. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 17. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 18. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 19. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 20. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 21. United States: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 22. United States: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 23. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 24. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 25. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 26. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 27. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 28. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 29. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 30. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 31. Canada: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 32. Canada: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 33. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 34. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 35. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 36. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 37. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 38. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 39. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 40. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 41. Mexico: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 42. Mexico: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 43. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 44. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 45. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 46. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 47. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 48. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 49. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 50. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 51. Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 52. Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 53. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 54. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 55. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 56. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 57. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 58. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 59. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 60. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 61. Germany: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 62. Germany: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 63. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 64. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 65. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 66. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 67. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 68. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 69. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 70. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 71. United Kingdom: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 72. United Kingdom: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 73. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 74. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 75. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 76. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 77. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 78. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 79. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 80. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 81. France: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 82. France: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 83. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 84. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 85. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 86. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 87. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 88. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 89. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 90. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 91. Italy: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 92. Italy: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 93. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 94. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 95. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 96. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 97. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 98. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 99. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 100. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 101. Spain: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 102. Spain: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 103. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 104. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 105. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 106. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 107. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 108. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 109. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 110. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 111. Rest of Europe: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 112. Rest of Europe: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 113. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 114. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 115. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 116. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 117. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 118. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 119. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 120. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 121. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 122. Asia Pacific: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 123. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 124. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 125. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 126. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 127. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 128. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 129. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 130. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 131. China: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 132. China: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 133. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 134. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 135. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 136. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 137. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 138. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 139. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 140. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 141. Japan: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 142. Japan: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 143. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 144. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 145. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 146. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 147. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 148. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 149. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 150. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 151. India: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 152. India: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 153. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 154. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 155. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 156. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 157. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 158. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 159. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 160. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 161. Australia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 162. Australia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 163. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 164. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 165. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 166. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 167. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 168. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 169. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 170. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 171. South Korea: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 172. South Korea: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 173. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 174. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 175. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 176. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 177. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 178. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 179. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 180. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 181. Rest of APAC: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 182. Rest of APAC: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 183. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 184. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 185. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 186. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 187. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 188. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 189. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 190. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 191. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 192. Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 193. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 194. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 195. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 196. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 197. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 198. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 199. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 200. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 201. Saudi Arabia: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 202. Saudi Arabia: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 203. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 204. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 205. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 206. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 207. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 208. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 209. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 210. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 211. South Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 212. South Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 213. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 214. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 215. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 216. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 217. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 218. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 219. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 220. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 221. United Arab Emirates: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 222. United Arab Emirates: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 223. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 224. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 225. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 226. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 227. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 228. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 229. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 230. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 231. Rest of Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 232. Rest of Middle East and Africa: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 233. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 234. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 235. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 236. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 237. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 238. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 239. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 240. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 241. South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 242. South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 243. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 244. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 245. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 246. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 247. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 248. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 249. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 250. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 251. Brazil: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 252. Brazil: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 253. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 254. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 255. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 256. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 257. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 258. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 259. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 260. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 261. Argentina: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 262. Argentina: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 263. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Product Type
Table 264. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Product Type
Table 265. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Drug Type
Table 266. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Drug Type
Table 267. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Therapeutic Area
Table 268. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Therapeutic Area
Table 269. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Route Of Administration
Table 270. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Route Of Administration
Table 271. Rest of South and Central America: Prescription Drugs Market - Revenue, 2021-2024 (US$ Billion) - by Distribution Channel
Table 272. Rest of South and Central America: Prescription Drugs Market - Revenue Forecast, 2025-2031 (US$ Billion) - by Distribution Channel
Table 273. Heat Map Analysis by Key Players
Table 274. Recent Organic Growth Strategies in the Prescription Drugs Market
Table 275. Recent Inorganic Growth Strategies in the Prescription Drugs Market
Table 276. Glossary of Terms, Medical Cables Market
LIST OF FIGURES
Figure 1. Prescription Drugs Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Prescription Drugs Market Revenue (US$ Billion), 2021-2031
Figure 5. Prescription Drugs Market Revenue (US$ Billion) Forecast Analysis, 2021-2031
Figure 6. Prescription Drugs Market Share (%) - by Product Type (2024 and 2031)
Figure 7. Branded: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 8. Generics: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 9. Prescription Drugs Market Share (%) - by Drug Type (2024 and 2031)
Figure 10. Small Molecule: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 11. Biologics and Biosimilar: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 12. Prescription Drugs Market Share (%) - by Therapeutic Area (2024 and 2031)
Figure 13. Oncology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 14. Cardiovascular Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 15. Neurological Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 16. Metabolic Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 17. Respiratory Diseases: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 18. Immunology: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 19. Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 20. Prescription Drugs Market Share (%) - by Route Of Administration (2024 and 2031)
Figure 21. Oral: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 22. Injectable: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 23. Topical: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 24. Others: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 25. Prescription Drugs Market Share (%) - by Distribution Channel (2024 and 2031)
Figure 26. Hospital Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 27. Retail Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 28. Online Pharmacies: Prescription Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 29. North America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
Figure 30. North America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 31. United States: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 32. Canada: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 33. Mexico: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 34. Europe: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
Figure 35. Europe: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 36. Germany: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 37. United Kingdom: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 38. France: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 39. Italy: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 40. Spain: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 41. Rest of Europe: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 42. Asia Pacific: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
Figure 43. Asia Pacific: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 44. China: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 45. Japan: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 46. India: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 47. Australia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 48. South Korea: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 49. Rest of APAC: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 50. Middle East and Africa: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
Figure 51. Middle East and Africa: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 52. Saudi Arabia: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 53. South Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 54. United Arab Emirates: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 55. Rest of Middle East and Africa: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 56. South and Central America: Prescription Drugs Market - Revenue, 2021-2031 (US$ Billion)
Figure 57. South and Central America: Prescription Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 58. Brazil: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 59. Argentina: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 60. Rest of South and Central America: Prescription Drugs Market - Revenue and Forecast, 2021-2031 (US$ Billion)
Figure 61. Company Positioning & Concentration
Figure 62. Growth Strategies in the Prescription Drugs Market

Companies Mentioned

The List of Companies in the Prescription Drugs Market include:
  • Johnson & Johnson
  • Pfizer Inc
  • Merck & Co Inc
  • Eli Lilly and Co
  • ESTEVE
  • AstraZeneca Plc
  • Sanofi SA
  • GSK Plc
  • F. Hoffmann-La Roche
  • Novartis AG
  • AbbVie Inc
  • Teva Pharmaceutical Industries Ltd

Table Information

Report AttributeDetails
No. of Pages329
PublishedJuly 2025
Forecast Period2024 - 2031
Estimated Market Value in 2024 1.44 Trillion
Forecasted Market Value by 2031 2.35 Trillion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Europe Generic Drugs Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Small Molecule, Drug Class, Route Of Administration, Type, Distribution Channel, and Country - Product Image

Europe Generic Drugs Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Small Molecule, Drug Class, Route Of Administration, Type, Distribution Channel, and Country

  • Report
  • 205 Pages
  • Europe
From
Prescription Drugs Market Report 2025 - Product Image

Prescription Drugs Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Dermatological Drugs Market Report 2024-2034 - Product Image

Dermatological Drugs Market Report 2024-2034

  • Report
  • 280 Pages
  • Global
From
Anti-obesity Prescription Drugs Market by Drug Class, Administration Route, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Anti-obesity Prescription Drugs Market by Drug Class, Administration Route, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Prescription Pain Medication Global Market Report 2025 - Product Image

Prescription Pain Medication Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.